Drug hypersensitivity syndrome induced by meglumine antimoniate

Am J Trop Med Hyg. 2009 Jun;80(6):939-40.

Abstract

We report a case of drug hypersensitivity syndrome (drug reaction with eosinophilia and systemic symptoms [DRESS]) induced by parenteral meglumine antimoniate (Glucantime) in a 40-year-old man who traveled to Bolivia and was treated for mucocutaneous leishmaniasis. Two weeks after starting therapy, the patient had fever, joint pain, a cutaneous eruption, and hypereosinophilia (1,358 cells/mm(3)). These symptoms resolved after drug withdrawal but reappeared upon reintroduction of the drug. Pentavalent antimonials should be definitively withdrawn in patients with hypereosinophilia > 1,000 cells/mm(3) accompanied by systemic manifestations consistent with DRESS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiprotozoal Agents / administration & dosage
  • Antiprotozoal Agents / adverse effects*
  • Antiprotozoal Agents / therapeutic use
  • Drug Hypersensitivity*
  • Humans
  • Leishmaniasis, Mucocutaneous / drug therapy
  • Male
  • Meglumine / administration & dosage
  • Meglumine / adverse effects*
  • Meglumine / therapeutic use
  • Meglumine Antimoniate
  • Organometallic Compounds / administration & dosage
  • Organometallic Compounds / adverse effects*
  • Organometallic Compounds / therapeutic use
  • Syndrome

Substances

  • Antiprotozoal Agents
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate